Detecting myositis as a cause of unexplained dysphagia: Proposal for a diagnostic algorithm.
aspiration
dysphagia
myositis
nutrition
pneumonia
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
revised:
21
11
2021
received:
28
07
2021
accepted:
01
12
2021
pubmed:
5
12
2021
medline:
5
4
2022
entrez:
4
12
2021
Statut:
ppublish
Résumé
Idiopathic inflammatory myopathy (IIM) can present with dysphagia as a leading or only symptom. In such cases, diagnostic evaluation may be difficult, especially if serological and electromyographical findings are unsuspicious. In this observational study we propose and evaluate a diagnostic algorithm to identify IIM as a cause of unexplained dysphagia. Over a period of 4 years, patients with unexplained dysphagia were offered diagnostic evaluation according to a specific algorithm: The pattern of dysphagia was characterized by instrumental assessment (swallowing endoscopy, videofluoroscopy, high-resolution manometry). Patients with an IIM-compatible dysphagia pattern were subjected to further IIM-focused diagnostic procedures, including whole-body muscle magnetic resonance imaging, electromyography, creatine kinase blood level, IIM antibody panel and, as a final diagnostic step, muscle biopsy. Muscle biopsies were taken from affected muscles. In cases where no other muscles showed abnormalities, the cricopharyngeal muscle was targeted. Seventy-two patients presented with IIM-compatible dysphagia as a leading or only symptom. As a result of the specific diagnostic approach, 19 of these patients were diagnosed with IIM according to the European League Against Rheumatism (EULAR) criteria. Eighteen patients received immunomodulatory therapy as a result of the diagnosis. Of 10 patients with follow-up swallowing examination, dysphagia improved in three patients after therapy, while it remained at least stable in six patients. Idiopathic inflammatory myopathy constitutes a potentially treatable etiology in patients with unexplained dysphagia. The diagnostic algorithm presented in this study helps to identify patients with an IIM-compatible dysphagia pattern and to assign those patients for further IIM-focused diagnostic and therapeutic procedures.
Sections du résumé
BACKGROUND AND PURPOSE
Idiopathic inflammatory myopathy (IIM) can present with dysphagia as a leading or only symptom. In such cases, diagnostic evaluation may be difficult, especially if serological and electromyographical findings are unsuspicious. In this observational study we propose and evaluate a diagnostic algorithm to identify IIM as a cause of unexplained dysphagia.
METHODS
Over a period of 4 years, patients with unexplained dysphagia were offered diagnostic evaluation according to a specific algorithm: The pattern of dysphagia was characterized by instrumental assessment (swallowing endoscopy, videofluoroscopy, high-resolution manometry). Patients with an IIM-compatible dysphagia pattern were subjected to further IIM-focused diagnostic procedures, including whole-body muscle magnetic resonance imaging, electromyography, creatine kinase blood level, IIM antibody panel and, as a final diagnostic step, muscle biopsy. Muscle biopsies were taken from affected muscles. In cases where no other muscles showed abnormalities, the cricopharyngeal muscle was targeted.
RESULTS
Seventy-two patients presented with IIM-compatible dysphagia as a leading or only symptom. As a result of the specific diagnostic approach, 19 of these patients were diagnosed with IIM according to the European League Against Rheumatism (EULAR) criteria. Eighteen patients received immunomodulatory therapy as a result of the diagnosis. Of 10 patients with follow-up swallowing examination, dysphagia improved in three patients after therapy, while it remained at least stable in six patients.
CONCLUSIONS
Idiopathic inflammatory myopathy constitutes a potentially treatable etiology in patients with unexplained dysphagia. The diagnostic algorithm presented in this study helps to identify patients with an IIM-compatible dysphagia pattern and to assign those patients for further IIM-focused diagnostic and therapeutic procedures.
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1165-1173Informations de copyright
© 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Références
Jean A. Brain stem control of swallowing: neuronal network and cellular mechanisms. Physiol Rev. 2001;81(2):929-969.
Miller AJ. The neurobiology of swallowing and dysphagia. Dev Disabil Res Rev. 2008;14(2):77-86.
Labeit B, Muhle P, Ogawa M, et al. FEES-based assessment of pharyngeal hypesthesia-proposal and validation of a new test procedure. Neurogastroenterol Motil. 2019;31(11):e13690.
Warnecke T, Labeit B, Schroeder J, et al. Neurogenic dysphagia: systematic review and proposal of a classification system. Neurology. 2021;96(6):e876-e889.
Labeit B, Mueller H, Muhle P, et al. Predicting dysphagia with national institute of health stroke scale: distinction between infra- and supratentorial region is essential. Cerebrovasc Dis. 2018;46(3-4):152-160.
Suttrup I, Warnecke T. Dysphagia in Parkinson's disease. Dysphagia. 2016;31(1):24-32.
Seçil Y, Arıcı Ş, İncesu TK, Gürgör N, Beckmann Y, Ertekin C. Dysphagia in Alzheimer's disease. Neurophysiol Clin. 2016;46(3):171-178.
Onesti E, Schettino I, Gori MC, et al. Dysphagia in amyotrophic lateral sclerosis: impact on patient behavior, diet adaptation, and riluzole management. Front Neurol. 2017;8:94.
Calcagno P, Ruoppolo G, Grasso MG, de Vincentiis M, Paolucci S. Dysphagia in multiple sclerosis-prevalence and prognostic factors. Acta Neurol Scand. 2002;105(1):40-43.
Pawlitzki M, Ahring S, Rolfes L, et al. Dysphagia in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease as a surrogate of brain involvement? Eur J Neurol. 2021;28(5):1765-1770.
Labeit B, Pawlitzki M, Ruck T, et al. The impact of dysphagia in myositis: a systematic review and meta-analysis. J Clin Med. 2020;9(7):2150.
Higo R, Nito T, Tayama N. Videofluoroscopic assessment of swallowing function in patients with myasthenia gravis. J Neurol Sci. 2005;231(1-2):45-48.
Warnecke T, Im S, Labeit B, et al. Detecting myasthenia gravis as a cause of unclear dysphagia with an endoscopic tensilon test. Ther Adv Neurol Disord. 2021;14:17562864211035544.
Buchholz DW. Neurogenic dysphagia: what is the cause when the cause is not obvious? Dysphagia. 1994;9(4):245-255.
Bottai M, Tjarnlund A, Santoni G, et al. EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open. 2017;3(2):e000507.
Oh TH, Brumfield KA, Hoskin TL, Kasperbauer JL, Basford JR. Dysphagia in inclusion body myositis: clinical features, management, and clinical outcome. Am J Phys Med Rehabil. 2008;87(11):883-889.
Williams RB, Grehan MJ, Hersch M, Andre J, Cook IJ. Biomechanics, diagnosis, and treatment outcome in inflammatory myopathy presenting as oropharyngeal dysphagia. Gut. 2003;52(4):471-478.
Peng A, Koffman BM, Malley JD, Dalakas MC. Disease progression in sporadic inclusion body myositis: observations in 78 patients. Neurology. 2000;55(2):296-298.
Labeit B, Muhle P, Suntrup-Krueger S, et al. Dysphagia as isolated manifestation of Jo-1 associated myositis? Front Neurol. 2019;10:739. 10.3389/fneur.2019.00739
Labeit B, Ahring S, Boehmer M, et al. Comparison of simultaneous swallowing endoscopy and videofluoroscopy in neurogenic dysphagia. J Am Med Dir Assoc. 2021;S1525-8610(21)00862-8. https://doi.org/10.1016/j.jamda.2021.09.026
Murata K-Y, Kouda K, Tajima F, Kondo T. A dysphagia study in patients with sporadic inclusion body myositis (s-IBM). Neurol Sci. 2012;33(4):765-770.
Olthoff A, Carstens P-O, Zhang S, et al. Evaluation of dysphagia by novel real-time MRI. Neurology. 2016;87(20):2132-2138.
Cox FM, Verschuuren JJ, Verbist BM, Niks EH, Wintzen AR, Badrising UA. Detecting dysphagia in inclusion body myositis. J Neurol. 2009;256(12):2009-2013.
Langdon PC, Mulcahy K, Shepherd KL, Low VH, Mastaglia FL. Pharyngeal dysphagia in inflammatory muscle diseases resulting from impaired suprahyoid musculature. Dysphagia. 2012;27(3):408-417.
Azola A, Mulheren R, Mckeon G, et al. Dysphagia in myositis: a study of the structural and physiologic changes resulting in disordered swallowing. Am J Phys Med Rehabil. 2020;99(5):404-408.
Labeit B, Perlova K, Pawlitzki M, et al. Predictors, outcome and characteristics of oropharyngeal dysphagia in idiopathic inflammatory myopathy. Muscle Nerve. 2021;63(6):874-880.
Marie I, Menard J-F, Hatron PY, et al. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res (Hoboken). 2010;62(12):1748-1755.
Casal-Dominguez M, Pinal-Fernandez I, Mego M, et al. High-resolution manometry in patients with idiopathic inflammatory myopathy: elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset. Muscle Nerve. 2017;56(3):386-392.
Crary MA, Mann GDC, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil. 2005;86(8):1516-1520.
Warnecke T, Teismann I, Zimmermann J, Oelenberg S, Ringelstein EB, Dziewas R. Fiberoptic endoscopic evaluation of swallowing with simultaneous Tensilon application in diagnosis and therapy of myasthenia gravis. J Neurol. 2008;255(2):224-230.
McHugh NJ, Tansley SL. Autoantibodies in myositis. Nat Rev Rheumatol. 2018;14(5):290-302.
Pluk H, van Hoeve BJA, van Dooren SHJ, et al. Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis. Ann Neurol. 2013;73(3):397-407.
Langmore SE. Endoscopic Evaluation and Treatment of Swallowing Disorders. Thieme; 2001.
Kornblum C, Broicher R, Walther E, et al. Cricopharyngeal achalasia is a common cause of dysphagia in patients with mtDNA deletions. Neurology. 2001;56(10):1409-1412.
Horvath OP, Zombori J, Halmos L, Bozoky B, Olah T. Pharyngeal dysphagia caused by isolated myogen dystrophy of musculus cricopharyngeus. Acta Chir Hung. 1998;37(1-2):51-58.
Eura N, Sugie K, Kiriyama T, Ueno S. Characteristic dysphagia as a manifestation of dermatomyositis on oropharyngeal muscle imaging. J Clin Rheumatol. 2015;21(2):105-106.
Otao G, Yamashita S-I, Kyoraku I, Shiomi K, Nakazato M. Dysphagia due to inflammation of oral muscles as the first symptom of dermatomyositis. Intern Med. 2007;46(12):923-924.
Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 1991;325(21):1487-1498.
Malik A, Hayat G, Kalia JS, Guzman MA. Idiopathic inflammatory myopathies: clinical approach and management. Front Neurol. 2016;7:64.
Riminton DS, Chambers ST, Parkin PJ, Pollock M, Donaldson IM. Inclusion body myositis presenting solely as dysphagia. Neurology. 1993;43(6):1241-1243.
Shapiro J, Martin S, DeGirolami U, Goyal R. Inflammatory myopathy causing pharyngeal dysphagia: a new entity. Ann Otol Rhinol Laryngol. 1996;105(5):331-335.
Devic P, Gallay L, Streichenberger N, Petiot P. Focal myositis: a review. Neuromuscul Disord. 2016;26(11):725-733.
Lynn SJ, Sawyers SM, Moller PW, O'Donnell JL, Chapman PT. Adult-onset inflammatory myopathy: north Canterbury experience 1989-2001. Intern Med J. 2005;35(3):170-173.
Cherin P, Pelletier S, Teixeira A, et al. Intravenous immunoglobulin for dysphagia of inclusion body myositis. Neurology. 2002;58(2):326.
Ko EH, Rubin AD. Dysphagia due to inclusion body myositis: case presentation and review of the literature. Ann Otol Rhinol Laryngol. 2014;123(9):605-608.
Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K. Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study. Neurology. 1997;48(3):712-716.
Singh S, Hamdy S. The upper oesophageal sphincter. Neurogastroenterol Motil. 2005;17(Suppl 1):3-12.
Sivarao DV, Goyal RK. Functional anatomy and physiology of the upper esophageal sphincter. Am J Med. 2000;108(Suppl 4a):27S-37S.
Bachmann G, Streppel M, Krug B, Neuen-Jacob E. Cricopharyngeal muscle hypertrophy associated with florid myositis. Dysphagia. 2001;16(4):244-248.
Murata K-Y, Kouda K, Tajima F, Kondo T. Balloon dilation in sporadic inclusion body myositis patients with dysphagia. Clin Med Insights Case Rep. 2013;6:1-7.
Liu LWC, Tarnopolsky M, Armstrong D. Injection of botulinum toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis. Can J Gastroenterol. 2004;18(6):397-399.
Schrey A, Airas L, Jokela M, Pulkkinen J. Botulinum toxin alleviates dysphagia of patients with inclusion body myositis. J Neurol Sci. 2017;380:142-147.